Solid Biosciences (SLDB)
(Delayed Data from NSDQ)
$8.95 USD
-0.35 (-3.76%)
Updated May 17, 2024 04:00 PM ET
After-Market: $8.96 +0.01 (0.11%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/12/24 |
---|---|
Current Quarter | -0.62 |
EPS Last Quarter | -0.64 |
Last EPS Surprise | -12.28% |
ABR | 1.40 |
Earnings ESP
|
-4.28% |
---|---|
Current Year | -2.68 |
Next Year | -2.49 |
EPS (TTM) | -3.94 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.40M | 4.40M | 17.60M | 17.70M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 4.40M | 4.40M | 17.60M | 17.70M |
Low Estimate | 4.40M | 4.40M | 17.60M | 17.70M |
Year ago Sales | 0.00M | 0.00M | 8.09M | 17.60M |
Year over Year Growth Est. | NA | NA | 117.45% | 0.57% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.62 | -0.67 | -2.68 | -2.49 |
# of Estimates | 6 | 6 | 7 | 6 |
Most Recent Consensus | -0.56 | -0.78 | -2.77 | -2.96 |
High Estimate | -0.51 | -0.50 | -2.03 | -1.03 |
Low Estimate | -0.71 | -0.78 | -3.63 | -3.76 |
Year ago EPS | -1.25 | -1.05 | -4.83 | -2.68 |
Year over Year Growth Est. | 50.40% | 36.19% | 44.51% | 7.33% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 1 | 1 | 1 |
Up Last 30 Days | 0 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 0 | 0 | 0 |
Down Last 7 Days | 1 | 1 | 1 | 1 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 2 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.62 | -0.67 | -2.68 | -2.49 |
7 Days Ago | -0.61 | -0.66 | -2.64 | -2.48 |
30 Days Ago | -0.61 | -0.66 | -2.64 | -2.48 |
60 Days Ago | -0.59 | -0.59 | -2.52 | -2.30 |
90 Days Ago | -0.91 | -0.86 | -3.46 | -1.42 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.65 | -0.74 | -2.73 | -2.58 |
Zacks Consensus Estimate | -0.62 | -0.67 | -2.68 | -2.49 |
Earnings ESP | -4.28% | -9.70% | -1.81% | -3.62% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.64 | -1.00 | -1.05 | -1.25 | NA |
Estimate | -0.57 | -1.01 | -1.20 | -1.52 | NA |
Difference | -0.07 | 0.01 | 0.15 | 0.27 | 0.09 |
Surprise | -12.28% | 0.99% | 12.50% | 17.76% | 4.74% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more